Two out of the three major indices are trading lower today with the

Dow Jones Industrial Average

(

^DJI

) trading down 88 points (-0.5%) at 17,785 as of Tuesday, May 31, 2016, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,627 issues advancing vs. 1,333 declining with 171 unchanged.

The Health Services industry currently sits up 0.4% versus the S&P 500, which is down 0.2%. On the negative front, top decliners within the industry include

Zimmer Biomet Holdings

(

ZBH

), down 1.2%,

Stryker

(

SYK

), down 0.9% and

Humana

(

HUM

), down 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3.

Grifols

(

GRFS

) is one of the companies pushing the Health Services industry higher today. As of noon trading, Grifols is up $0.46 (2.8%) to $16.56 on heavy volume. Thus far, 1.6 million shares of Grifols exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $16.11-$16.58 after having opened the day at $16.19 as compared to the previous trading day's close of $16.10.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Grifols, S.A., a biopharmaceutical company, develops, manufactures, and distributes plasma derivative products in the United States, Canada, Spain, rest of the European Union, and internationally. Grifols has a market cap of $11.0 billion and is part of the health care sector. Shares are down 0.6% year-to-date as of the close of trading on Friday. Currently there is 1 analyst who rates Grifols a buy, 1 analyst rates it a sell, and 1 rates it a hold.

TheStreet Ratings rates

Grifols

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations, growth in earnings per share and expanding profit margins. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Grifols Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Anthem

(

ANTM

) is up $0.75 (0.6%) to $131.45 on average volume. Thus far, 808,210 shares of Anthem exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $130.44-$131.97 after having opened the day at $131.39 as compared to the previous trading day's close of $130.70.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial and Specialty Business, Government Business, and Other. Anthem has a market cap of $34.4 billion and is part of the health care sector. Shares are down 6.3% year-to-date as of the close of trading on Friday. Currently there are 8 analysts who rate Anthem a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates

Anthem

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Anthem Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

Express Scripts

(

ESRX

) is up $0.38 (0.5%) to $75.35 on light volume. Thus far, 1.2 million shares of Express Scripts exchanged hands as compared to its average daily volume of 4.4 million shares. The stock has ranged in price between $74.45-$75.59 after having opened the day at $74.61 as compared to the previous trading day's close of $74.97.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States, Canada, and Europe. The company operates through two segments, PBM and Other Business Operations. Express Scripts has a market cap of $47.4 billion and is part of the health care sector. Shares are down 14.2% year-to-date as of the close of trading on Friday. Currently there are 8 analysts who rate Express Scripts a buy, 1 analyst rates it a sell, and 8 rate it a hold.

TheStreet Ratings rates

Express Scripts

as a

buy

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, notable return on equity, good cash flow from operations and reasonable valuation levels. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

Express Scripts Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).